{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:26:15Z","timestamp":1782390375780,"version":"3.54.5"},"reference-count":44,"publisher":"Informa UK Limited","issue":"30","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Amgen and Merck-Pfizer"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2217\/fon-2023-0414","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T14:06:00Z","timestamp":1693836360000},"page":"2017-2027","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["COLUMBUS-AD: Phase III Study of Adjuvant Encorafenib + Binimetinib in Resected Stage IIB\/IIC BRAF V600-Mutated Melanoma"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-6935","authenticated-orcid":false,"given":"Alexander CJ","family":"van Akkooi","sequence":"first","affiliation":[{"name":"Melanoma Institute Australia,the University of Sydney & Royal Prince Alfred Hospital,\r40 Rocklands Road Wollstonecraft, Sydney 2065, NSW, \rAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-9587","authenticated-orcid":false,"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital (UKSH),\rArnold-Heller-Stra\u00dfe 3, 24105,\rKiel, \rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8894-3545","authenticated-orcid":false,"given":"Georgina V","family":"Long","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, University of Sydney,& Mater & Royal North Shore Hospitals,\r40 Rocklands Road Wollstonecraft, Sydney 2065, NSW,\rAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-8959","authenticated-orcid":false,"given":"Mario","family":"Mandala","sequence":"additional","affiliation":[{"name":"University of Perugia,Ospedale Santa Maria della Misericordia, Piazzale Giorgio Menghini,\r3, 06129,\rPerugia, \rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7066-0587","authenticated-orcid":false,"given":"Michal","family":"Kicinski","sequence":"additional","affiliation":[{"name":"EORTC Headquarters,\rAvenue Emmanuel Mounier 83\/11, 1200,\rBrussels, \rBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Govaerts","sequence":"additional","affiliation":[{"name":"EORTC Headquarters,\rAvenue Emmanuel Mounier 83\/11, 1200,\rBrussels, \rBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Klauck","sequence":"additional","affiliation":[{"name":"Pierre Fabre,Medical & Patient\/Consumer Division,\r33 avenue Emile Zola, 92100, \rBoulogne-Billancourt, \rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Ouali","sequence":"additional","affiliation":[{"name":"Pierre Fabre,Medical & Patient\/Consumer Division,\rLanglade, \rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8875-2164","authenticated-orcid":false,"given":"Paul C","family":"Lorigan","sequence":"additional","affiliation":[{"name":"Christie NHS Foundation Trust,\rWilmslow Road Manchester M20 4BX,\rUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4278-040X","authenticated-orcid":false,"given":"Alexander MM","family":"Eggermont","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht,\rHeidelberglaan 100, 3584 CX Utrecht,\rThe Netherlands"},{"name":"Comprehensive Cancer Center Munich,Technical University Munich & Ludwig Maximiliaan University,\rMarchioninistra\u00dfe 15, 81377 Munich,\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"e_1_3_6_3_1","volume-title":"Cutaneous melanoma: etiology and therapy.","author":"Matthews NH","year":"2017","unstructured":"Matthews NH , LiW-Q, QureshiAA, WeinstockMA, ChoE. Epidemiology of melanoma. In: Cutaneous melanoma: etiology and therapy.WardWH, FarmaJM. (Eds). Codon Publications, Brisbane, Australia (2017)."},{"key":"e_1_3_6_4_1","unstructured":"International Agency for Research on Cancer\n. Cancer over time (2021). https:\/\/gco.iarc.fr\/overtime (Accessed 23December2021)."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32585"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.2217\/mmt-2019-0022"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2012.10.002"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.104"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.4327"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01903-5"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy229"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6513-7"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5642-0"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00559-9"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26214"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.04.015"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61546-8"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00202"},{"key":"e_1_3_6_19_1","first-page":"705","volume-title":"Cutaneous Melanoma.","author":"Perez MC","year":"2019","unstructured":"Perez MC , TanabeKK, AriyanCEet al. Local and recurrent regional metastases of melanoma. In: Cutaneous Melanoma.BalchCM, AtkinsMB, GarbeCet al. et al. (Eds). 705\u2013737 (2019)."},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.670726"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz411"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0018"},{"key":"e_1_3_6_23_1","volume-title":"Society of Melanoma Research (SMR) International Congress.","author":"Long G","year":"2022","unstructured":"Long G . Adjuvant therapy with nivolumab versus placebo in patients with stage IIB\/C melanoma (CheckMate 76K) [late-breaking plenary abstract]. Presented at: Society of Melanoma Research (SMR) International Congress. (19 October 2022)."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30497-2"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30142-6"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408868"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60898-4"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005493"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708539"},{"key":"e_1_3_6_30_1","unstructured":"US Food and Drug Administration\n. FDA approves pembrolizumab for adjuvant treatment of Stage IIB or IIC melanoma (2021). www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pembrolizumab-adjuvant-treatment-stage-iib-or-iic-melanoma (Accessed 3December2021)."},{"key":"e_1_3_6_31_1","unstructured":"European Medicines Agency\n. KEYTRUDA (pembrolizumab) 25mg\/mL concentrate for solution for infusion: summary of product characteristics (2022). www.ema.europa.eu\/documents\/product-information\/keytruda-epar-product-information_en.pdf (Accessed 28July2022)."},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.03.010"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.08.044"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00600-w"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.03.198"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2020.11.006"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000491"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806303182605"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640314"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2019.057"},{"key":"e_1_3_6_41_1","unstructured":"US Food and Drug Administration\n. BRAFTOVI\u2122 (encorafenib) capsules for oral use: highlights of prescribing information (2018). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210496lbl.pdf (Accessed 15June2022)."},{"key":"e_1_3_6_42_1","unstructured":"US Food and Drug Administration\n. MEKTOVI \u00ae (binimetinib) tablets for oral use: highlights of prescribing information (2018). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210498lbl.pdf (Accessed 15June2022)."},{"key":"e_1_3_6_43_1","unstructured":"European Medicines Agency\n. Braftovi (encorafenib) 50 mg\/75 mg hard capsules: summary of product characteristics (2018). www.ema.europa.eu\/en\/documents\/product-information\/braftovi-epar-product-information_en.pdf (Accessed 6December2022)."},{"key":"e_1_3_6_44_1","unstructured":"European Medicines Agency\n. Mektovi (binimetinib) 15 mg film-coated tablets: summary of product characteristics (2018). www.ema.europa.eu\/en\/documents\/product-information\/mektovi-epar-product-information_en.pdf (Accessed 6December2022)."},{"key":"e_1_3_6_45_1","volume-title":"Melanoma: cutaneous, version 2.2023 \u2014 March 10, 2023.","author":"National Comprehensive Cancer Network","year":"2023","unstructured":"National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Melanoma: cutaneous, version 2.2023 \u2014 March 10, 2023. (2023). www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf (Accessed June 9 2023)."},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21409"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:45Z","timestamp":1719125145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":44,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.2217\/fon-2023-0414"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0414","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}